PharmStar Pharmaceuticals, Inc. announced that Dr. James Carlson has accepted a position on the board of directors for the company, and will also serve as the Chairman for the Medical Advisory Board.

PharmStar Pharmaceuticals, Inc. announced that it has signed a commitment letter for a 3-year wholesale distribution agreement for its signature product line, Aquaprin. Alert Medical Supply has committed to order a total of $5 million of Aquaprin over a three-year period, beginning upon PharmStar's initial operations for the production of Aquaprin, which Pharmstar's management is planning for the third quarter of 2012. The agreement will require the company to meet a minimum order requirement over the period of the contract before additional product can be made available to other distribution channels. AMS will look to expand its distribution agreement to include extension products that have been developed by the company as they become available in the product supply channel. AMS is also making a direct investment in PharmStar through its Preferred D offering to further the company's goals of meeting its production deadlines.

PharmStar Pharmaceuticals, Inc. announced that Dr. Antonio Hernandez has accepted an invitation to join the company's Medical Advisory Board (MAB). The Medical Advisory Board will be instrumental in overseeing the protocols established for the company's 3rd party claims testing, and develop testing protocols for future product offerings by the company. Dr. Hernandez has served as a hematopathologist in Orlando, Florida since 2009. Before moving to Florida, he served in the same capacity for Kaiser Permanente in Los Angeles, beginning in 1994.